All updates
All updates
today 48文献与产业新闻精选评分6464 顶刊论文（社媒热度）精选评分6464 Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.
顶刊论文（社媒热度）评分4747 Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain.
文献与产业新闻精选评分6363 ESC: Amgen CMO flags Repatha 'inflection' amid new data on mortality benefit
顶刊论文（社媒热度）精选评分7272 Survodutide Once Weekly for the Treatment of Adults with Obesity.
文献与产业新闻评分2727 Teva autoimmune antibody notches ph. 2 win in celiac disease
文献与产业新闻评分3535 A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer
文献与产业新闻评分4545 TYK2 inhibitor miss pushes Alumis toward precision strategy for lupus
文献与产业新闻精选评分6565 What CAR T’s new safety concern could mean for immune reset competition
顶刊论文（社媒热度）评分4343 Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703).
顶刊论文（社媒热度）精选评分5959 Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial.
文献与产业新闻评分1515 STAT+: Novartis gets multiple sclerosis win with BTK inhibitor
文献与产业新闻精选评分5555 STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more
文献与产业新闻评分3434 Paxlovid did not help long Covid, study finds
中文产业新闻精选Chinese source评分6060 诺华与BMS因3例死亡暂停自免领域CAR-T临床试验
中文产业新闻精选Chinese source评分6666 3例患者死亡，诺华与BMS暂停自免CD19 CAR-T多项试验
中文产业新闻精选Chinese source评分6868 安进 Repatha 三期 VESALIUS-CV 分析显示高危一级预防人群全因死亡风险降低 20%
中文产业新闻精选Chinese source评分7373 帕母医疗PADN-HF-PH研究登NEJM与ESC Hot Line，PADN联合GDMT降低PH-LHD恶化风险51%
中文产业新闻精选Chinese source评分6363 恒瑞ANGPTL3单抗芮弗西拜单抗HoFH三期研究入选ESC 2026 LBA，LDL-C相对安慰剂下降64.2%
文献与产业新闻精选评分5252 Novartis claims MS win as Rhapsido clears phase 3 with ‘no liver safety signal’
文献与产业新闻评分3838 Alumis crushed by midstage lupus flop but plots path to phase 3 for TYK2 inhibitor
顶刊论文（社媒热度）评分4848 Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial.
顶刊论文（社媒热度）精选评分6666 Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
文献与产业新闻评分3535 GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
文献与产业新闻评分3737 Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule
文献与产业新闻评分4242 Boston Scientific halts sales of angiographic catheters amid 2 serious injuries
文献与产业新闻精选评分6868 Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial
文献与产业新闻评分4949 A 12-week, double-blind, quasi-randomized, placebo-controlled study to evaluate the efficacy and safety of Coleus forskohlii (Forcslim) on body weight loss
JAMA Oncology评分4545 Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in ES-SCLC
JAMA Oncology评分5252 Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer
JAMA Oncology评分4747 Ultralow-Dose IL 10–Expressing CAR T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Cancer Discovery精选评分5959 Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti–CTLA-4 in Melanoma with Primary Resistance to Anti–PD-1
JAMA Oncology评分5151 Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer
JAMA Oncology评分4545 Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma
Cancer Discovery评分5353 Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study
JAMA Oncology评分55 Generalized Purpuric Papules and Nodules in a Man
Cancer Discovery评分5454 First-Line HER2 ADC and Anti–PD-1 Plus Chemo Shows Efficacy in Gastric Cancer
文献与产业新闻精选评分6464 UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
文献与产业新闻评分2525 ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM
文献与产业新闻评分2020 A winner, a loser, and a mid-stage signal from a major cardiology research conference